CSIMarket


HOSPIRA, INC.  (HSP)
Other Ticker:  
 

HOSPIRA, INC.

HSP's Fundamental analysis






Looking into Hospira growth rates, revenue grew by 14.12 % in III. Quarter 2014 from the same quarter a year ago. Ranking at No. 1256

Major Pharmaceutical Preparations industry recorded growth of revenues by 3.73 %

Hospira's net income grew by 8247.37 % in III. Quarter 2014 year on year, above company average,

More on HSP's Growth


Hospira
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Hospira PEG ratio is at 0 Hospira realized cash outflow of $ -0.53per share in trailing twelve-month period.
Company
0
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.13.
With annual estimated revenue growth of 2.5 % for 2014, Company's P/S ratio improved to 0.

More on HSP's Valuation
 
 Total Debt (Millions $) 1,762
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 260,094
 Net Income/Employee (TTM) $ 19,465
 Receivable Turnover (TTM) 7.4
 Tangible Book Value (Per Share $) 12.30

Hospira
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Hospira PEG ratio is at 0 Hospira realized cash outflow of $ -0.53per share in trailing twelve-month period.
Company
0
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.13.
With annual estimated revenue growth of 2.5 % for 2014, Company's P/S ratio improved to 0.

More on HSP's Valuation

  Market Capitalization (Millions $) -
  Shares Outstanding (Millions) 172
  Employees 17,000
  Revenues (TTM) (Millions $) 4,422
  Net Income (TTM) (Millions $) 331
  Cash Flow (TTM) (Millions $) -90
  Capital Exp. (TTM) (Millions $) -29
  Total Debt (Millions $) 1,762
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 260,094
  Net Income/Employee(TTM) $ 19,465
  Receivable Turnover Ratio (TTM) 7.4
  Tangible Book Value (Per Share $) 12.30

  Market Capitalization (Millions $) -
  Shares Outstanding (Millions) 172
  Employees 17,000
  Revenues (TTM) (Millions $) 4,422
  Net Income (TTM) (Millions $) 331
  Cash Flow (TTM) (Millions $) -90
  Capital Exp. (TTM) (Millions $) -29

HSP's Profitability Comparisons
Hospira achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2014 to 19.77 % from 8.76 % in II. Quarter.

Hospira net profit margin of 13.78 % is currently ranking no. 32 in Major Pharmaceutical Preparations industry, ranking no. 84 in Healthcare sector and number 1223 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 2.36
  Total Debt to Equity (MRQ) 0.53
  Tangible Leverage Ratio (MRQ) 1.49
  Asset Turnover Ratio (TTM) 0.7
  Inventory Turnover Ratio (TTM) 1.87



Hospira achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2014 to 19.77 % from 8.76 % in II. Quarter.

Hospira net profit margin of 13.78 % is currently ranking no. 32 in Major Pharmaceutical Preparations industry, ranking no. 84 in Healthcare sector and number 1223 in S&P 500.

More on HSP's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HZN's Profile

Stock Price

HZN's Financials

Business Description

Fundamentals

Charts & Quotes

HZN's News

Suppliers

HZN's Competitors

Customers & Markets

Economic Indicators

HZN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071